Key facts
- Notable investors include Capital Development Investment Fund (China).
- Status: Privately Held (backing).
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Huishan Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Huishan Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Huishan Medical
Provider and developer of cell drugs designed for immune disorders. The company focuses on research and development of cell drugs, precise diagnostic products and immune cell storage solutions, enabling clients with cell drugs.
- Sector
- Healthcare
- HQ
- Guangzhou, China
- Founded
- 2020
- Ownership
- Privately Held (backing)
Huishan Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Huishan Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Huishan Medical in its N-PORT filings yet. We sweep new filings monthly.